-
1
-
2
-
3
EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
Published 2018-12-01Subjects: Get full text
Article -
4
Real-time platelet P2Y12 receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy
Published 2025-01-01Subjects: Get full text
Article -
5
Sustainable Immunomodulatory via Macrophage P2Y12 Inhibition Mediated Bioactive Patche for Peritendinous Antiadhesion
Published 2025-01-01Subjects: Get full text
Article -
6
-
7
-
8
-
9
GPD2 inhibition impairs coagulation function via ROS/NF-κB/P2Y12 pathway
Published 2025-07-01Subjects: Get full text
Article -
10
Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial
Published 2022-02-01Subjects: Get full text
Article -
11
-
12
-
13
-
14
NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
Published 2018-03-01Subjects: Get full text
Article -
15
-
16
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI
Published 2025-04-01Subjects: Get full text
Article -
17
Antiplatelet Therapy and Platelet Activity Testing for Neurointerventional Procedures
Published 2025-01-01Subjects: Get full text
Article -
18
Unravelling the target landscape of tranylcypromines for new drug discovery
Published 2025-06-01Subjects: Get full text
Article -
19
Effect of Ticagrelor Versus Clopidogrel After Off‐Pump Coronary Artery Bypass Grafting on Postoperative Atrial Fibrillation: A Cohort Study
Published 2024-08-01Subjects: Get full text
Article -
20
The cellular distribution of P2X7, P2Y6, and P2Y12 during or after pilocarpine-induced status epilepticus and literature review
Published 2024-12-01Subjects: Get full text
Article